Kidney cancer: Sunitinib has similar efficacy irrespective of age in mRCC.
David
D
Killock
D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D011758:Pyrroles / Q000009:adverse effects* / Q000627:therapeutic use*
D007211:Indoles; D011758:Pyrroles